Netherlands: Market and legal data analysis of the cannabis sector

The uncertain fate of IHDCs in Europe: could a general ban be on the horizon?

Written by Tiziana Cauli | 12th April 2024

In this part of a series of articles celebrating the tenth anniversary of Tamarind Intelligence, we look at how the landscape of intoxicating hemp-derived cannabinoids (IHDCs) across Europe has changed over the years ...

How could a new government affect cannabinoid policy in the Netherlands?

Written by CannIntelligence | 17th October 2023

The nearly 18m people of the Netherlands face uncertainty following the collapse of the government this summer. The Cabinet is currently overseeing the nation with a “caretaker” status until the 22nd November general election ...

22nd Century Group acquires a UK cannabinoid distributor for $650K

Written by Antonia Di Lorenzo | 30th January 2023

US company 22nd Century Group has acquired privately held UK cannabinoid distributor RX Pharmatech for an up-front payment of $650,000 in cash and stock ...

HHC and other intoxicating cannabinoids move within legal limbo in Europe

Written by Tiziana Cauli | 16th September 2022

As debate over the legalisation of recreational cannabis involves a growing number of European countries, the commercial demand for legal psychoactive alternatives to controlled cannabinoid variants is on the rise ...

Three nations aiming to lead EU states toward joined-up cannabis reforms

Written by CannIntelligence | 9th August 2022

Germany, Luxembourg and Malta have taken the first step towards working together on the legalisation and regulation of recreational cannabis, leading a wave of potential reform across the EU ...

Canadian and US firms set sights on promising German cannabis market

Written by Lorraine Mullaney | 22nd June 2022

North American cannabis firms are attempting to muscle in on the German medical cannabis scene – possibly in an attempt to establish themselves in the market before a recreational regime is established ...

EU officially recognises first CBG-rich hemp variety among registered plants

Written by Tiziana Cauli | 13th May 2022

The EU has granted official recognition to a hemp variety rich in cannabigerol (CBG) by including a new cannabinoid strain in its database of registered plant varieties ...

Two studies seek to show the benefits of cannabinoids for liver health

Written by Lorraine Mullaney | 5th November 2021

A research team at the University Medical Center Groningen (UMCG) in the Netherlands recently launched a three-year study into whether medicinal cannabis oil can help to regress liver-cancer tumours ...

Lidl has a change of heart, removing edible hemp products from its shelves

Written by CannIntelligence | 21st September 2021

Discount supermarket chain Lidl has removed foods containing hemp from its stores in Germany, Ireland and the Netherlands amid concerns that the products contain excessive levels of THC ...

GenCanna's latest white label purchase deepens penetration of UK and Europe

Written by Freddie Dawson | 15th September 2021

GenCanna continues to bet on the future of UK bulk and white label CBD products with the purchase of another company specialising in those areas ...

A long process – Europe's still asking questions about novel food submission

Written by CannIntelligence | 14th July 2021

A year and eight months after Cibdol submitted its novel food application for EU authorisation of synthetically produced CBD, the Swiss company is still fielding questions from the European Food Safety Authority (ESFA) ...

Euro cross-party group to push for EU harmony on medicinal cannabis rules

Written by CannIntelligence | 12th July 2021

A new cross-party European parliamentary group wants to help patients across the European Union get better access to medical cannabis and advance the EU’s cannabis resolution of 2019 ...

Nordic Oil seeks €5m and ‘emotional investment’ through crowd-funding

Written by CannIntelligence | 16th June 2021

Nordic Oil could become the largest European CBD brand to raise money through crowd-funding as it seeks to raise €3m-€5m through the Seedrs platform ...

US market to top $3bn in two years, but Swiss remain the biggest CBD users

Written by CannIntelligence | 15th March 2021

Swiss consumers are head-for-head the biggest purchasers of CBD products, according to CBD-Intel’s 2021 market size analysis. Meanwhile, we predict big growth in a number of other markets, and a shift in the most popular...

Dutch health ministry provides relief for UK patients forgotten in Brexit deal

Written by CannIntelligence | 25th January 2021

Dutch officials have granted a six-month reprieve to find a solution to an omission in the Brexit negotiations that threatens to deprive British epilepsy patients of access to cannabis-based medicines ...

Government aid available to European companies hit by COVID-19 measures

Written by CannIntelligence | 28th May 2020

CBD companies based in Europe have a range of possible options for government assistance to help them through the various strictures imposed due to the coronavirus pandemic ...

Test methods put to the test as firms are accused of exceeding THC limits

Written by CannIntelligence | 17th March 2020

Unclear testing standards for CBD oil in the UK have led to uncertainty over test results on THC and CBD content for many popular CBD products ...

Epidiolex passes another clinical trial for treatment of Dravet syndrome

Written by Freddie Dawson | 11th March 2020

Results from a successful phase three clinical trial on the use of Epidiolex to treat drug-resistant Dravet syndrome have been published in the JAMA Neurology journal ...

Toothpaste giant enters CBD market: business news in brief

Written by CannIntelligence | 26th February 2020

Toothpaste giant Colgate is entering the CBD market, researchers have created a laser scanner that can tell the difference between legal hemp and potentially illegal cannabis, and wrestling legend Kevin Nash has become the latest...

LATEST ALERTS

The uncertain fate of IHDCs in Europe: could a general ban be on the horizon?

Written by Tiziana Cauli | 12th April 2024

How could a new government affect cannabinoid policy in the Netherlands?

Written by CannIntelligence | 17th October 2023

22nd Century Group acquires a UK cannabinoid distributor for $650K

Written by Antonia Di Lorenzo | 30th January 2023

HHC and other intoxicating cannabinoids move within legal limbo in Europe

Written by Tiziana Cauli | 16th September 2022

Three nations aiming to lead EU states toward joined-up cannabis reforms

Written by CannIntelligence | 9th August 2022

Canadian and US firms set sights on promising German cannabis market

Written by Lorraine Mullaney | 22nd June 2022

EU officially recognises first CBG-rich hemp variety among registered plants

Written by Tiziana Cauli | 13th May 2022

Two studies seek to show the benefits of cannabinoids for liver health

Written by Lorraine Mullaney | 5th November 2021

Lidl has a change of heart, removing edible hemp products from its shelves

Written by CannIntelligence | 21st September 2021

GenCanna's latest white label purchase deepens penetration of UK and Europe

Written by Freddie Dawson | 15th September 2021

A long process – Europe's still asking questions about novel food submission

Written by CannIntelligence | 14th July 2021

Euro cross-party group to push for EU harmony on medicinal cannabis rules

Written by CannIntelligence | 12th July 2021

Nordic Oil seeks €5m and ‘emotional investment’ through crowd-funding

Written by CannIntelligence | 16th June 2021

US market to top $3bn in two years, but Swiss remain the biggest CBD users

Written by CannIntelligence | 15th March 2021

Dutch health ministry provides relief for UK patients forgotten in Brexit deal

Written by CannIntelligence | 25th January 2021

Government aid available to European companies hit by COVID-19 measures

Written by CannIntelligence | 28th May 2020

Test methods put to the test as firms are accused of exceeding THC limits

Written by CannIntelligence | 17th March 2020

Epidiolex passes another clinical trial for treatment of Dravet syndrome

Written by Freddie Dawson | 11th March 2020

Toothpaste giant enters CBD market: business news in brief

Written by CannIntelligence | 26th February 2020

Sign up to our newsletter

LATEST ALERTS

Written by Tiziana Cauli | 12th April 2024

Written by CannIntelligence | 17th October 2023

Written by Antonia Di Lorenzo | 30th January 2023

Written by Tiziana Cauli | 16th September 2022

Written by CannIntelligence | 9th August 2022

Written by Lorraine Mullaney | 22nd June 2022

Written by Tiziana Cauli | 13th May 2022

Written by Lorraine Mullaney | 5th November 2021

Written by CannIntelligence | 21st September 2021

Written by Freddie Dawson | 15th September 2021

Written by CannIntelligence | 14th July 2021

Written by CannIntelligence | 12th July 2021

Written by CannIntelligence | 16th June 2021

Written by CannIntelligence | 15th March 2021

Written by CannIntelligence | 25th January 2021

Written by CannIntelligence | 28th May 2020

Written by CannIntelligence | 17th March 2020

Written by Freddie Dawson | 11th March 2020

Written by CannIntelligence | 26th February 2020

Sign up to our newsletter

Start your FREE trial